Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.69 -0.07 (-1.86%)
As of: Oct 2, 2026 · 1:50 PM EDT

Whitehawk Therapeutics (WHWK) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Whitehawk Therapeutics (WHWK) reported Liabilities and Shareholders Equity of $193.99 million for Q2 2026, up 7.3% from $180.82 million a year earlier and up 52.5% from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Whitehawk Therapeutics posted Liabilities and Shareholders Equity of $150.83 million, up 114.5% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 51.6% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $70.32 million in FY2024 (-46.9%), $132.42 million in FY2023 (-28.1%), $184.24 million in FY2022 (+16.7%) and $157.91 million in FY2021 (+738.8%).
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • Year over year, Liabilities and Shareholders Equity gained in five of the last eight quarters, with growth averaging 34.3%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 738.8%); the low point was Q4 2024 (a decline of 46.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $127.23 million (Q1 2026), $150.83 million (Q4 2025) and $167.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Whitehawk Therapeutics 311.65 Mn 311.65 Mn - 193.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193.99 Mn
Mar 31, 2026 127.23 Mn
Dec 31, 2025 150.83 Mn
Sep 30, 2025 167.02 Mn
Jun 30, 2025 180.82 Mn
Mar 31, 2025 234.00 Mn
Dec 31, 2024 70.32 Mn
Sep 30, 2024 85.70 Mn
Jun 30, 2024 101.62 Mn
Mar 31, 2024 111.07 Mn
Dec 31, 2023 132.42 Mn
Sep 30, 2023 139.66 Mn
Jun 30, 2023 151.23 Mn
Mar 31, 2023 170.65 Mn
Dec 31, 2022 184.24 Mn
Sep 30, 2022 194.10 Mn
Jun 30, 2022 128.64 Mn
Mar 31, 2022 142.32 Mn
Dec 31, 2021 157.91 Mn
Sep 30, 2021 168.77 Mn
API Access

Whitehawk Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=WHWK&period=max&api_key=YOUR_API_KEY